Showing results (1191-1200 of 1,523) with videos related to

Sort By:
Pageof 153
Lung Cancer (Amsterdam, Netherlands)|September 23, 2015
Rare discrepancies in a driver gene alteration within histologically heterogeneous primary lung cancersWen-zhao Zhong, Jian Su, Fang-ping Xu, et al.
Angiology|May 22, 2024
The FAITHS<sup>2</sup> Model Predicts Functional Disability in Patients With Acute Ischemic StrokeMeng Wang, Ying Han, Qi Zhou, et al.
Discover Oncology|May 27, 2026
Crizotinib or vebreltinib response and resistance in advanced non-small cell lung cancer with MET exon 14 skippingJiao Yang, Cheng-Di Weng, Han-Min Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 30, 2016
Intracranial Efficacy of Crizotinib Versus Chemotherapy in Patients With Advanced ALK-Positive Non-Small-Cell Lung Cancer: Results From PROFILE 1014Benjamin J Solomon, Federico Cappuzzo, Enriqueta Felip, et al.
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association|July 12, 2021
Synergism of rMV-Hu191 with cisplatin to treat gastric cancer by acid sphingomyelinase-mediated apoptosis requiring integrity of lipid raft microdomainsYao Lv, Chu-di Zhang, Yi-Long Wang, et al.
BMC Medicine|June 1, 2022
Subsequent treatments beyond progression on osimertinib in EGFR-mutated NSCLC and leptomeningeal metastasesMei-Mei Zheng, Yang-Si Li, Hai-Yan Tu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|May 15, 2020
Advances and future directions in the use of mobile health in supportive cancer care: proceedings of the 2019 MASCC Annual Meeting symposiumRaymond J Chan, Doris Howell, Maryam B Lustberg, et al.
CNS Neuroscience & Therapeutics|March 28, 2012
High-sensitivity C-reactive protein is a strong risk factor for death after acute ischemic stroke among ChineseYue Huang, Jing Jing, Xing-Quan Zhao, et al.
The Oncologist|September 17, 2014
Lung cancer treatment disparities in China: a question in need of an answerLu-Lu Yang, Xu-Chao Zhang, Xue-Ning Yang, et al.
Neurological Research|June 11, 2009
Can baseline magnetic resonance angiography (MRA) status become a foremost factor in selecting optimal acute stroke patients for recombinant tissue plasminogen activator (rt-PA) thrombolysis beyond 3 hours?Li Ma, Pei-Yi Gao, Yan Lin, et al.
Pageof 153